Somatostatin receptor 2

SSTR2
Identifiers
Aliases SSTR2, Somatostatin receptor 2
External IDs MGI: 98328 HomoloGene: 37427 GeneCards: SSTR2
RNA expression pattern


More reference expression data
Orthologs
Species Human Mouse
Entrez

6752

20606

Ensembl

ENSG00000180616

ENSMUSG00000047904

UniProt

P30874

P30875

RefSeq (mRNA)

NM_001050

NM_001042606
NM_009217

RefSeq (protein)

NP_001041.1

NP_001036071.1
NP_033243.2

Location (UCSC) Chr 17: 73.17 – 73.18 Mb Chr 11: 113.62 – 113.63 Mb
PubMed search [1] [2]
Wikidata
View/Edit HumanView/Edit Mouse

Somatostatin receptor type 2 is a protein that in humans is encoded by the SSTR2 gene.[3]

Function

Somatostatin acts at many sites to inhibit the release of many hormones and other secretory proteins. The biologic effects of somatostatin are probably mediated by a family of G protein-coupled receptors that are expressed in a tissue-specific manner. SSTR2 is a member of the superfamily of receptors having seven transmembrane segments and is expressed in highest levels in cerebrum and kidney.[4]

Interactions

Somatostatin receptor 2 has been shown to interact with SHANK2.[5]

Therapeutic targeting

Most pituitary adenomas express SSTR2, but other somatostatin receptors are also found.<[6] Somatostatin analogs (i.e. Octreotide, Lanreotide ) are used to stimulate this receptors, and thus to inhibit further tumor proliferation.[7]

See also

References

  1. ↑ "Human PubMed Reference:".
  2. ↑ "Mouse PubMed Reference:".
  3. ↑ Yamada Y, Stoffel M, Espinosa R, Xiang KS, Seino M, Seino S, Le Beau MM, Bell GI (Feb 1993). "Human somatostatin receptor genes: localization to human chromosomes 14, 17, and 22 and identification of simple tandem repeat polymorphisms". Genomics. 15 (2): 449–52. doi:10.1006/geno.1993.1088. PMID 8449518.
  4. ↑ "Entrez Gene: SSTR2 somatostatin receptor 2".
  5. ↑ Zitzer H, Hönck HH, Bächner D, Richter D, Kreienkamp HJ (Nov 1999). "Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain". The Journal of Biological Chemistry. 274 (46): 32997–3001. doi:10.1074/jbc.274.46.32997. PMID 10551867.
  6. ↑ Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibanski A (Apr 1995). "Somatostatin receptor subtype gene expression in pituitary adenomas". The Journal of Clinical Endocrinology and Metabolism. 80 (4): 1386–92. doi:10.1210/jcem.80.4.7714115. PMID 7714115.
  7. ↑ Zatelli MC, Ambrosio MR, Bondanelli M, Uberti EC (Apr 2007). "Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds". European Journal of Endocrinology / European Federation of Endocrine Societies. 156 Suppl 1: S29–35. doi:10.1530/eje.1.02352. PMID 17413185.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This article is issued from Wikipedia - version of the 5/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.